Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Lyell Immunopharma (LYEL) Institutional Ownership

Lyell Immunopharma logo
$16.13 -0.38 (-2.30%)
Closing price 04:00 PM Eastern
Extended Trading
$16.16 +0.04 (+0.22%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Lyell Immunopharma (NASDAQ:LYEL)

Current
Institutional Ownership
Percentage
66.05%
Number of
Institutional Buyers
(last 12 months)
27
Total
Institutional Inflows
(last 12 months)
$138.52M
Number of
Institutional Sellers
(last 12 months)
31
Total
Institutional Outflows
(last 12 months)
$768.23M
Get LYEL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lyell Immunopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LYEL Institutional Buying and Selling by Quarter

Lyell Immunopharma Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE33,321$668K0.0%+314.2%0.143%
5/19/2026 RBF Capital LLC44,094$885K0.0%-40.9%0.189%
5/14/2026 Renaissance Technologies LLC116,411$2.34M0.0%+194.8%0.499%
5/14/2026 Walleye Capital LLC22,207$445K0.0%N/A0.095%
5/7/2026 Dimensional Fund Advisors LP47,888$959K0.0%N/A0.205%
2/19/2026 Invesco Ltd.98,649$3.04M0.0%N/A0.464%
2/18/2026 venBio Partners LLC337,697$10.39M4.8%-28.7%1.590%
2/18/2026 Ikarian Capital LLC41,081$1.26M0.1%-6.2%0.193%
2/18/2026 Millennium Management LLC58,651$1.81M0.0%-53.2%0.276%
2/18/2026MWG Caph Ltd1,008,116$31.03M42.9%N/A4.746%
2/18/2026 Boothbay Fund Management LLC9,516$293K0.0%-22.2%0.045%
2/17/2026 ExodusPoint Capital Management LP8,511$262K0.0%N/A0.040%
2/17/2026 RBF Capital LLC74,585$2.30M0.1%-22.0%0.351%
2/16/2026 Barclays PLC15,967$491K0.0%+1,239.5%0.075%
2/13/2026 Marshall Wace LLP73,315$2.26M0.0%N/A0.345%
2/13/2026 Charles Schwab Investment Management Inc.85,423$2.63M0.0%+7.4%0.402%
2/13/2026 State Street Corp51,472$1.58M0.0%+52.5%0.242%
2/12/2026 Jane Street Group LLC12,409$382K0.0%N/A0.058%
2/12/2026 GSK plc1,512,659$46.56M5.8%N/A7.122%
2/12/2026 Renaissance Technologies LLC39,490$1.22M0.0%-38.3%0.186%
2/11/2026 BBR Partners LLC6,834$210K0.0%N/A0.032%
2/10/2026 Goldman Sachs Group Inc.96,675$2.98M0.0%N/A0.455%
2/9/2026 Geode Capital Management LLC162,997$5.02M0.0%+25.1%0.767%
11/17/2025 Susquehanna International Group LLP16,159$262K0.0%-27.9%0.076%
11/17/2025 Millennium Management LLC125,361$2.04M0.0%+140.0%0.591%
11/17/2025 Foresite Capital Management V LLC477,078$7.75M7.1%+17.3%2.248%
11/17/2025 Bank of America Corp DE4,679$76K0.0%-80.3%0.022%
11/17/2025 Almitas Capital LLC577,807$9.38M2.1%-0.4%2.723%
11/14/2025 ARCH Venture Management LLC2,759,072$44.81M9.1%+51.5%14.362%
11/14/2025 Two Sigma Investments LP20,827$338K0.0%+107.0%0.108%
11/13/2025Takeda Pharmaceutical Co. Ltd.54,887$891K5.4%+33.3%0.286%
11/7/2025Vanguard Group Inc.779,004$12.65M0.0%+76.0%4.055%
10/14/2025Clarius Group LLC19,958$324K0.0%+4.3%0.104%
8/28/2025 China Universal Asset Management Co. Ltd.2,966$26K0.0%-94.9%0.015%
8/15/2025 Orland Properties Ltd754,698$6.67M2.8%-95.0%3.929%
8/15/2025MWG Management Ltd.1,008,116$8.91M17.2%-95.0%5.248%
8/15/2025 HSG Holding Ltd152,299$1.35M0.1%-95.0%0.793%
8/15/2025 Boothbay Fund Management LLC12,234$108K0.0%-95.0%0.064%
8/15/2025 Bridgeway Capital Management LLC18,000$159K0.0%N/A0.094%
8/15/2025 Bank of America Corp DE23,758$210K0.0%-74.7%0.124%
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
8/15/2025 ARCH Venture Management LLC1,820,634$16.11M5.4%N/A9.478%
8/14/2025 Orbimed Advisors LLC51,727$457K0.0%N/A0.335%
8/14/2025 Raymond James Financial Inc.7,900$70K0.0%-95.0%0.051%
8/14/2025 Canada Pension Plan Investment Board29,411$260K0.0%-95.0%0.190%
8/14/2025 The Manufacturers Life Insurance Company 24,419$216K0.0%-95.2%0.158%
8/14/2025 RBF Capital LLC100,000$884K0.0%N/A0.647%
8/13/2025 Marshall Wace LLP10,580$94K0.0%N/A0.068%
8/13/2025 Walleye Capital LLC29,230$258K0.0%N/A0.189%
8/13/2025 Decheng Capital LLC595,466$5.26M1.2%-95.0%3.852%
8/13/2025 Invesco Ltd.12,809$113K0.0%-96.6%0.083%
8/12/2025 Foresite Capital Management V LLC406,652$3.60M4.5%-95.0%2.630%
8/12/2025 Foresite Capital Management IV LLC800,399$7.08M5.7%-95.0%5.177%
8/12/2025 JPMorgan Chase & Co.3,369$30K0.0%-98.3%0.022%
8/8/2025 Geode Capital Management LLC103,270$913K0.0%-97.7%0.668%
8/8/2025Takeda Pharmaceutical Co. Ltd.41,165$364K1.9%-95.0%0.266%
8/1/2025 Alphabet Inc.293,256$2.59M0.1%-95.0%1.980%
7/28/2025 TD Asset Management Inc50,232$444K0.0%-95.0%0.339%
7/22/2025 Johnson & Johnson41,165$368K0.1%-95.0%0.278%
7/22/2025Clarius Group LLC19,138$169K0.0%-95.2%0.129%
6/27/2025 Goldman Sachs Group Inc.358,592$193K0.0%-42.8%2.421%
6/18/2025 Voya Investment Management LLC50,329$27K0.0%-4.9%0.340%
5/29/2025Rhumbline Advisers235,694$127K0.0%-16.2%0.080%
5/21/2025Acadian Asset Management LLC660,899$354K0.0%+204.2%0.224%
5/19/2025Jane Street Group LLC64,241$35K0.0%-73.2%0.022%
5/16/2025Goldman Sachs Group Inc.358,592$193K0.0%-42.8%0.121%
5/16/2025Jacobs Levy Equity Management Inc.558,979$301K0.0%-59.6%0.189%
5/16/2025AQR Capital Management LLC174,279$94K0.0%+773.5%0.059%
5/16/2025Almitas Capital LLC2,482,606$1.34M0.4%+136.3%0.841%
5/12/2025Nuveen LLC641,173$345K0.0%N/A0.217%
5/12/2025Invesco Ltd.378,880$204K0.0%-7.0%0.128%
5/9/2025Charles Schwab Investment Management Inc.1,604,676$863K0.0%-2.5%0.543%
4/17/2025Exchange Traded Concepts LLC246,349$133K0.0%+82.4%0.083%
4/8/2025Rhumbline Advisers235,694$127K0.0%-16.2%0.080%
2/19/2025Public Employees Retirement System of Ohio99,307$64K0.0%N/A0.034%
2/17/2025venBio Partners LLC7,102,190$4.55M2.7%N/A2.431%
2/17/2025Two Sigma Investments LP204,501$131K0.0%-15.4%0.070%
2/17/2025Two Sigma Advisers LP306,400$196K0.0%+143.8%0.105%
2/17/2025Nuveen Asset Management LLC641,173$410K0.0%-25.1%0.219%
2/17/2025Orbimed Advisors LLC3,103,623$1.99M0.0%-49.0%1.062%
2/17/2025Millennium Management LLC957,507$613K0.0%+34.8%0.328%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.308,551$197K0.0%+13.4%0.106%
2/17/2025Jacobs Levy Equity Management Inc.1,385,301$887K0.0%N/A0.474%
2/17/2025Graham Capital Management L.P.52,136$33K0.0%N/A0.018%
2/17/2025Foresite Capital Management V LLC8,133,047$5.21M4.3%N/A2.784%
2/17/2025D. E. Shaw & Co. Inc.966,265$618K0.0%+104.4%0.331%
2/17/2025BNP Paribas Financial Markets253,669$162K0.0%N/A0.087%
2/17/2025Almitas Capital LLC1,050,520$672K0.1%N/A0.360%
2/14/2025Jane Street Group LLC239,439$153K0.0%-16.8%0.082%
2/14/2025Northern Trust Corp1,310,224$839K0.0%-3.4%0.448%
2/14/2025Decheng Capital LLC11,909,341$7.62M1.6%N/A4.076%
Nobody Understands Why Trump Is Invading Iran (here’s the answer) (Ad)

Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.tc pixel

Discover the real reason behind the Iran strikes before markets react
2/14/2025Boothbay Fund Management LLC406,234$260K0.0%+190.4%0.139%
2/14/2025Price T Rowe Associates Inc. MD6,910,749$4.42M0.0%-6.0%2.365%
2/14/2025Johnson & Johnson823,317$527K0.1%N/A0.282%
2/13/2025Barclays PLC258,380$165K0.0%+7.4%0.088%
2/13/2025Renaissance Technologies LLC1,612,146$1.03M0.0%+716.7%0.552%
2/13/2025Wells Fargo & Company MN94,320$60K0.0%+27.8%0.032%
2/12/2025RPO LLC66,378$42K0.0%N/A0.023%
2/12/2025Geode Capital Management LLC4,137,264$2.65M0.0%+2.9%1.416%
2/12/2025Takeda Pharmaceutical Co. Ltd.823,317$527K2.0%N/A0.282%
2/12/2025JPMorgan Chase & Co.433,265$277K0.0%+347.8%0.148%


LYEL Institutional Ownership - Frequently Asked Questions

During the previous two years, 83 institutional investors and hedge funds held shares of Lyell Immunopharma. The most heavily invested institutionals were GSK plc ($46.56M), ARCH Venture Management LLC ($44.81M), MWG Caph Ltd ($31.03M), Vanguard Group Inc. ($12.65M), venBio Partners LLC ($10.39M), WuXi AppTec Co. Ltd. ($10.20M), and Almitas Capital LLC ($9.38M).Learn more on Lyell Immunopharma's institutional investors.

66.05% of Lyell Immunopharma's stock is owned by institutional investors. Learn more on LYEL's institutional investor holdings.

Of the 58 institutional investors that purchased Lyell Immunopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($11.91M), Foresite Capital Management V LLC ($8.20M), venBio Partners LLC ($7.10M), Opaleye Management Inc. ($3.36M), ARCH Venture Management LLC ($2.76M), Almitas Capital LLC ($2.48M), and GSK plc ($1.51M).

Institutional investors have bought a total of 6,978,077 shares in the last 24 months. This purchase volume represents approximately $138.52M in transactions.

Of the 30 institutional investors that sold Lyell Immunopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: MWG Management Ltd. ($19.15M), Foresite Capital Management IV LLC ($15.21M), Orland Properties Ltd ($14.34M), Decheng Capital LLC ($11.31M), Foresite Capital Management V LLC ($7.73M), Alphabet Inc. ($5.57M), and Geode Capital Management LLC ($4.30M).

Institutional investors have sold a total of 86,143,897 shares in the last 24 months. This volume of shares sold represents approximately $768.23M in transactions.


Related Companies

This page (NASDAQ:LYEL) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel